Ranked [title] Word list | Historiographs | Help Glossary HistCite Guide About |
Nodes: 91, Authors: 95, Journals: 37, Outer References: 1666, Words: 330
Yearly output | Document Type | Language | Institution | Institution with Subdivision | Country |
View: Overview | Sorted by GCS. |
# | Word | Pubs | TLCS | TGCS |
---|---|---|---|---|
1 | EFFICACY | 10 | 13 | 784 |
2 | TUBERCULOSIS | 8 | 7 | 687 |
3 | PREVENTION | 3 | 5 | 673 |
4 | LITERATURE | 2 | 5 | 630 |
5 | PUBLISHED | 2 | 5 | 630 |
6 | VACCINE | 3 | 5 | 524 |
7 | BCG | 2 | 5 | 498 |
8 | METAANALYSIS | 1 | 5 | 498 |
9 | TOMOGRAPHY | 9 | 13 | 285 |
10 | HEALTH | 6 | 0 | 244 |
11 | COST-EFFECTIVENESS | 5 | 0 | 224 |
12 | AIDS | 4 | 2 | 219 |
13 | ASSESSMENT | 1 | 0 | 215 |
14 | COMPARISON | 1 | 0 | 215 |
15 | METHODS | 2 | 0 | 215 |
16 | OUTCOMES | 1 | 0 | 215 |
17 | PREFERENCES | 1 | 0 | 215 |
18 | ACUTE | 2 | 0 | 178 |
19 | ADMISSION | 2 | 0 | 170 |
20 | ALTERNATIVES | 2 | 0 | 170 |
21 | CORONARY-CARE-UNIT | 2 | 0 | 170 |
22 | CARE | 2 | 0 | 169 |
23 | LOW | 1 | 0 | 169 |
24 | MYOCARDIAL-INFARCTION | 1 | 0 | 169 |
25 | PATIENTS | 3 | 0 | 169 |
26 | PROBABILITY | 1 | 0 | 169 |
27 | PUBLIC-HEALTH | 3 | 1 | 166 |
28 | EDUCATION | 1 | 2 | 162 |
29 | OBSTACLES | 1 | 2 | 162 |
30 | PREVENT | 1 | 2 | 162 |
# | Word | Pubs | TLCS | TGCS |
31 | PROSPECTS | 1 | 2 | 162 |
32 | MEDICAL | 9 | 3 | 159 |
33 | UNITED-STATES | 3 | 3 | 159 |
34 | BACILLUS-CALMETTE-GUERIN | 2 | 0 | 158 |
35 | COMPUTED | 6 | 8 | 155 |
36 | VACCINATION | 3 | 0 | 155 |
37 | EVALUATION | 4 | 3 | 152 |
38 | BODY | 7 | 8 | 141 |
39 | CIMETIDINE | 1 | 1 | 133 |
40 | INTRODUCTION | 1 | 1 | 133 |
41 | PEPTIC-ULCER | 1 | 1 | 133 |
42 | SURGICAL-TREATMENT | 1 | 1 | 133 |
43 | TRENDS | 1 | 1 | 133 |
44 | COMPUTERIZED | 4 | 5 | 132 |
45 | INFANTS | 1 | 0 | 132 |
46 | METAANALYSES | 1 | 0 | 132 |
47 | NEWBORNS | 1 | 0 | 132 |
48 | EFFECT | 2 | 5 | 130 |
49 | BENEFIT | 2 | 1 | 129 |
50 | RISK | 2 | 1 | 129 |
51 | DIAGNOSTIC | 2 | 5 | 128 |
52 | CLINICAL | 2 | 8 | 126 |
53 | CRANIAL | 2 | 5 | 125 |
54 | PLANS | 1 | 5 | 125 |
55 | THERAPEUTIC | 1 | 5 | 125 |
56 | VALUE | 4 | 4 | 123 |
57 | XENOTRANSPLANTATION | 2 | 1 | 120 |
58 | COLLECTIVE | 1 | 1 | 118 |
59 | INDIVIDUAL | 1 | 1 | 118 |
60 | UNCERTAINTY | 1 | 1 | 118 |
# | Word | Pubs | TLCS | TGCS |
61 | TECHNOLOGY-ASSESSMENT | 2 | 1 | 113 |
62 | CONSIDERATIONS | 3 | 0 | 111 |
63 | RUBELLA | 3 | 0 | 110 |
64 | PRACTICES | 2 | 1 | 106 |
65 | CASE | 2 | 2 | 105 |
66 | SCREENING | 3 | 0 | 99 |
67 | COMPULSORY | 2 | 0 | 94 |
68 | HUMAN-IMMUNODEFICIENCY-VIRUS | 1 | 0 | 94 |
69 | PREMARITAL | 2 | 0 | 94 |
70 | TECHNICAL | 1 | 0 | 94 |
71 | DOCTORS | 2 | 2 | 91 |
72 | NUMBERS | 1 | 2 | 88 |
73 | PERTUSSIS | 2 | 0 | 87 |
74 | REPORT | 2 | 0 | 87 |
75 | SUMMARY | 2 | 0 | 87 |
76 | VACCINES | 2 | 0 | 87 |
77 | PLANNING | 3 | 5 | 85 |
78 | PROSPECTIVE-STUDY | 2 | 4 | 68 |
79 | RADIATION-THERAPY | 2 | 4 | 68 |
80 | SCANNING | 2 | 4 | 68 |
81 | TREATMENT | 2 | 4 | 68 |
82 | FINDINGS | 1 | 1 | 65 |
83 | META-ANALYSES | 1 | 1 | 65 |
84 | ADVERSE | 1 | 0 | 62 |
85 | EVENTS | 1 | 0 | 62 |
86 | FOLLOWING | 1 | 0 | 62 |
87 | INSTITUTE-OF-MEDICINE | 1 | 0 | 62 |
88 | CULTURES | 1 | 0 | 53 |
89 | STOOL | 1 | 0 | 53 |
90 | INFECTIONS | 2 | 1 | 52 |
# | Word | Pubs | TLCS | TGCS |
91 | HIV | 5 | 0 | 50 |
92 | MODEL | 2 | 0 | 49 |
93 | PREVALENCE | 3 | 0 | 46 |
94 | MORATORIUM | 2 | 0 | 44 |
95 | HIV-INFECTED | 1 | 0 | 43 |
96 | RISKS | 1 | 0 | 43 |
97 | TRAVELERS | 1 | 0 | 43 |
98 | CALL | 1 | 0 | 42 |
99 | CORONARY | 1 | 0 | 42 |
100 | GLOBAL | 4 | 0 | 42 |
101 | REPERFUSION | 1 | 0 | 42 |
102 | THERAPY | 1 | 0 | 42 |
103 | THROMBOLYSIS | 1 | 0 | 42 |
104 | XENOTRANSPLANTS | 1 | 0 | 42 |
105 | INFLUENCE | 2 | 0 | 40 |
106 | SOCIAL | 3 | 0 | 38 |
107 | CLINICAL-EVALUATION | 1 | 0 | 37 |
108 | MEDICAL-PRACTICE | 1 | 0 | 37 |
109 | NEW | 3 | 3 | 35 |
110 | STRATEGIES | 4 | 0 | 34 |
111 | COMPUTER | 2 | 2 | 33 |
112 | SIMULATION | 2 | 2 | 33 |
113 | CHRONIC | 2 | 0 | 32 |
114 | DIMENSIONS | 1 | 0 | 30 |
115 | IMPACT | 2 | 0 | 29 |
116 | ALTERNATIVE | 2 | 0 | 27 |
117 | BLEACH | 1 | 0 | 27 |
118 | DRUG-USERS | 1 | 0 | 27 |
119 | MODELING | 1 | 0 | 27 |
120 | PREVENTING | 1 | 0 | 27 |
# | Word | Pubs | TLCS | TGCS |
121 | PROGRAMS | 1 | 0 | 27 |
122 | ACHIEVEMENT | 1 | 0 | 26 |
123 | CHALLENGE | 1 | 0 | 26 |
124 | CONTROL | 2 | 2 | 26 |
125 | GEOGRAPHIC | 1 | 0 | 26 |
126 | LATITUDE | 1 | 0 | 26 |
127 | POLICIES | 2 | 2 | 26 |
128 | USING | 1 | 2 | 26 |
129 | ACQUISITION | 1 | 2 | 25 |
130 | ADVERSE-EFFECTS | 1 | 0 | 25 |
131 | ANESTHESIOLOGISTS | 1 | 2 | 25 |
132 | APPLICATION | 1 | 2 | 25 |
133 | BULLETS | 1 | 0 | 25 |
134 | EXAMPLES | 1 | 2 | 25 |
135 | INSTITUTE | 2 | 0 | 25 |
136 | KNOWLEDGE | 1 | 2 | 25 |
137 | MAGIC | 1 | 0 | 25 |
138 | MEDICINE | 3 | 0 | 25 |
139 | RECENT | 1 | 2 | 25 |
140 | RICOCHET | 1 | 0 | 25 |
141 | ARTHRITIS | 1 | 0 | 23 |
142 | COUNTRIES | 1 | 0 | 22 |
143 | DEVELOPED | 1 | 0 | 22 |
144 | ENGAGEMENT | 1 | 0 | 22 |
145 | PURSUIT | 1 | 0 | 22 |
146 | RELEVANCE | 1 | 0 | 22 |
147 | ACTION | 2 | 0 | 19 |
148 | MULTIDRUG-RESISTANT | 2 | 0 | 19 |
149 | NEED | 1 | 0 | 19 |
150 | CORONARY-ARTERY | 2 | 0 | 18 |
# | Word | Pubs | TLCS | TGCS |
151 | DISEASE | 2 | 0 | 18 |
152 | DISTRIBUTION | 1 | 1 | 17 |
153 | EPIDEMIC | 2 | 0 | 17 |
154 | SCANNERS | 1 | 1 | 17 |
155 | STATUS | 1 | 1 | 17 |
156 | DIAGNOSE | 1 | 0 | 15 |
157 | IMPLICATIONS | 1 | 0 | 15 |
158 | COST | 2 | 0 | 14 |
159 | FUTURE-DIRECTIONS | 2 | 0 | 14 |
160 | AGE-SPECIFIC | 1 | 0 | 13 |
161 | CAPABILITY | 1 | 0 | 13 |
162 | DYSRHYTHMIA | 1 | 0 | 13 |
163 | EXPONENTIAL | 1 | 0 | 13 |
164 | INCREASE | 1 | 0 | 13 |
165 | INFECTION | 3 | 0 | 13 |
166 | MALES | 1 | 0 | 13 |
167 | MOTIVATION | 1 | 0 | 13 |
168 | VENTRICULAR | 1 | 0 | 13 |
169 | CHANGE | 1 | 0 | 12 |
170 | CHOLECYSTECTOMY | 1 | 0 | 12 |
171 | CLINICAL-VALUE | 1 | 0 | 12 |
172 | COMPUTED-TOMOGRAPHY | 3 | 0 | 12 |
173 | CONSTRUCTION | 1 | 0 | 12 |
174 | DECISION | 1 | 0 | 12 |
175 | DECREASE | 2 | 0 | 12 |
176 | LENGTH | 1 | 0 | 12 |
177 | LIMITS | 1 | 0 | 12 |
178 | NEEDS | 2 | 0 | 12 |
179 | OPTIONS | 1 | 0 | 12 |
180 | PAYING | 1 | 0 | 12 |
# | Word | Pubs | TLCS | TGCS |
181 | POLICY | 2 | 0 | 12 |
182 | REVIEW | 2 | 0 | 12 |
183 | SHORTER | 1 | 0 | 12 |
184 | SIMPLE | 1 | 0 | 12 |
185 | STAY | 1 | 0 | 12 |
186 | TECHNOLOGIC | 1 | 0 | 12 |
187 | TIME | 1 | 0 | 12 |
188 | TREES | 1 | 0 | 12 |
189 | USES | 1 | 0 | 12 |
190 | MANAGEMENT | 1 | 0 | 11 |
191 | POLYMYALGIA | 1 | 0 | 11 |
192 | RHEUMATICA | 1 | 0 | 11 |
193 | AMERICAN | 1 | 0 | 9 |
194 | BLOOD-SUPPLY | 2 | 1 | 9 |
195 | CURRICULUM | 1 | 0 | 9 |
196 | DAMAGE | 1 | 0 | 9 |
197 | ENCEPHALOPATHY | 1 | 0 | 9 |
198 | ENOUGH | 1 | 1 | 9 |
199 | EVALUATIONS | 1 | 0 | 9 |
200 | INNOVATIONS | 1 | 0 | 9 |
Page 1 of 2: [ 1 2 ]